Growth Metrics

Nautilus Biotechnology (NAUT) Cash from Investing Activities (2020 - 2026)

Nautilus Biotechnology has reported Cash from Investing Activities over the past 7 years, most recently at $14.2 million for Q1 2026.

  • Quarterly results put Cash from Investing Activities at $14.2 million for Q1 2026, down 27.05% from a year ago — trailing twelve months through Mar 2026 was $29.9 million (down 52.77% YoY), and the annual figure for FY2025 was $35.2 million, down 46.83%.
  • Cash from Investing Activities reached $14.2 million in Q1 2026 per NAUT's latest filing, up from $787000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $37.1 million in Q4 2024 and bottomed at -$64.1 million in Q4 2022.
  • Median Cash from Investing Activities over the past 5 years was $13.1 million (2023), compared with a mean of $2.7 million.
  • The largest annual shift saw Cash from Investing Activities crashed 1156.32% in 2022 before it skyrocketed 733.88% in 2024.
  • Over 5 years, Cash from Investing Activities stood at -$64.1 million in 2022, then soared by 35.9% to -$41.1 million in 2023, then soared by 190.37% to $37.1 million in 2024, then crashed by 97.88% to $787000.0 in 2025, then surged by 1708.51% to $14.2 million in 2026.
  • Business Quant data shows Cash from Investing Activities for NAUT at $14.2 million in Q1 2026, $787000.0 in Q4 2025, and $452000.0 in Q3 2025.